journal: NeuroImmune Pharmacology and Therapeutics
BY 4.0 license Open Access Published since May 20, 2022

NeuroImmune Pharmacology and Therapeutics

ISSN: 2750-6665
Editor-in-chief: Howard E. Gendelman